Review of Charts From Amish/Mennonite Variant PA Patients

Sponsor
University of Pittsburgh (Other)
Overall Status
Recruiting
CT.gov ID
NCT03159026
Collaborator
(none)
150
1
96.3
1.6

Study Details

Study Description

Brief Summary

The natural history of patients with PA-AMV has not been systematically studied before and there is no published data in the literature about this condition since 1980. There is no evidence-based approach to care of these patients, particularly the younger patients who may no come to medical attention until significant cardiac problems develop. Through systematic review of existing medical records on essentially all known patient with this condition, investigators plan to develop an evidence-based management plan for preventive care of these patients.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    The study is designed to provide a comprehensive description of the clinical and biochemical features of propionic academia, Amish/Mennonite variant (PA-AMV). From these data, the investigators hope to identify biomarkers for assessment of clinical course and efficacy of ongoing management.

    The investigators plan to identify essentially all known patients who have the Amish/Mennonite variant of Propionic academia (PA-AMV) through collaboration with clinicians who proved care to this extended community. Signed consents include permission to access life-long medical records to allow investigators to define the natural history of this biochemical variant condition. This will include a description the clinical and biochemical features and natural history of patients with propionic acidemia in the Amish/Mennonite population. In particular, there is interest in the cardiac complications of this variant, so investigators will analyze EKG, echo and cardiac MRI findings in above patients. These data will be used to Identify biomarkers for clinical assessment and ongoing management.

    There has been no published data on patients with PA-AMV since 1980. Accumulated clinical experience with PA Amish/Mennonite variant patients suggests that these patients tend to have less severe clinical features compared to classic PA. Severe neonatal metabolic decompensation and ketoacidosis are not present in Amish/Mennonite patients we have followed. Describing the natural history and clinical course is essential in this group of patients to further guide their management. There is currently no evidence-based approach to care of these patients, but rather individual medical centers manage patients symptomatically and differently. A uniform, data-driven approach to patient management is needed.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    150 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Cross-Sectional
    Official Title:
    Chart Review of Patients Who Have the Amish/Mennonite Variant of Propionic Acidemia
    Actual Study Start Date :
    Apr 6, 2017
    Anticipated Primary Completion Date :
    Apr 15, 2025
    Anticipated Study Completion Date :
    Apr 15, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Clinical and biochemical natural history of Amish/Mennonite PA variant [Through study completion, an average of one year.]

      Chart review to describe clinical and biochemical features of Amish/Mennonite PA variant

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Patients homozygous for the PCCB c.606A>G mutation
    Exclusion Criteria:
    • Patients who are not homozygous for the PCCB c.1606A>G mutation

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Children's Hospital of Pittsburgh Pittsburgh Pennsylvania United States 15224

    Sponsors and Collaborators

    • University of Pittsburgh

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Lina Ghaloul Gonzalez, Research Professor, University of Pittsburgh
    ClinicalTrials.gov Identifier:
    NCT03159026
    Other Study ID Numbers:
    • PRO16110176
    First Posted:
    May 18, 2017
    Last Update Posted:
    May 18, 2022
    Last Verified:
    May 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Lina Ghaloul Gonzalez, Research Professor, University of Pittsburgh
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of May 18, 2022